A Study Evaluating MM-310 in Patients With Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Solid Tumors|Urothelial Carcinoma|Gastric Carcinoma|Squamous Cell Carcinoma of the Head and Neck|Ovarian Cancer|Pancreatic Ductal Adenocarcinoma|Prostate Adenocarcinoma|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Triple Negative Breast Cancer|Endometrial Carcinoma|Soft Tissue Sarcoma
Interventions: DRUG: MM-310
Sponsor: Merrimack Pharmaceuticals